PRINCETON, N.J., Oct. 7, 2025 /PRNewswire/ -- Soligenix, Inc. (SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare ...
Soligenix Inc. (NASDAQ:SNGX) jumped 16% in premarket trading on Tuesday after announcing that an independent Data Monitoring Committee (DMC) had found no safety concerns in the ongoing Phase 3 FLASH2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results